Biotechnology News

November 9, 2012

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Meda AB (STO:MEDAA): Group net sales reached SEK 9,796 million (9,400). At fixed currency rates, sales increased 5%. EBITDA amounted to SEK 3,043 million (3,493), corresponding to a 31.1% margin...

November 9, 2012

BERKELEY, Calif. & LOS ANGELES--(BUSINESS WIRE)--Plexxikon today announced that updated Phase 1 clinical data of Zelboraf® (vemurafenib) were presented at the Society for Melanoma Research (SMR) 2012 Congress, held November 8-11 in Los...

November 9, 2012

BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that Patrick J. Mahaffy, the Company’s president and CEO, will present at the Credit Suisse Annual Healthcare Conference on Thursday, November 15, at 11:30am...

November 8, 2012

ATLANTA--(BUSINESS WIRE)--Iconic Therapeutics, Inc. announced today that Dr. Christine Gonzales will present the results of its recently completed Phase 1 study of hI-con1TM in wet adult macular degeneration (wet AMD) patients at the American...

November 8, 2012

SAN FRANCISCO--(BUSINESS WIRE)--McKesson Corporation (NYSE:MCK) today announced that Jeff Campbell, executive vice president and chief financial officer, will present at the Credit Suisse 2012 Healthcare Conference in Phoenix at 10:00 a.m. MT on...

November 8, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Vertex will webcast its presentation at the Credit Suisse 2012 Healthcare Conference on Wednesday, November 14, 2012 at 8:00 a.m. MT (10:00...

November 8, 2012

SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience, Inc. (NASDAQ: PURE), the creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced it has named Peter C. Wulff as Chief Financial Officer, effective November 5, 2012. Mr....

November 8, 2012

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX) announced today that it will present at the 24th Annual Piper Jaffray Healthcare Conference in New York on Tuesday, November 27th at 12:00 p.m. (CT). The live webcast of...

November 8, 2012

LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today reported on its cash balance as of September 30, 2012 and financial results for the third quarter of 2012 and provided an update on the Company’s previously...

November 8, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has authorized an increase of its quarterly cash dividend from $0.13 to $0.15 per common...

November 8, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--InSite Vision reports third quarter 2012 financial results and updates on the advancement of its clinical-stage programs.

November 8, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that its upcoming conference call on its third quarter financial results will also provide...

November 8, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Human Metabolome Technologies, Inc., (HMT) expands to U.S., opening office in Cambridge, Mass

November 8, 2012

BETHESDA, Md.--(BUSINESS WIRE)--Sucampo Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2012 Financial and Operating Results

November 8, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (OTCBB: ACTC) (“ACT” or the “Company”), a leader in the field of regenerative medicine, announced today third quarter financial results for the period ended September 30, 2012....

November 8, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals (NYSE MKT: NAVB) Announces Third Quarter 2012 Financial Results: –Business Update / Quarterly Conference Call November 8, 2012, at 5:00 PM EST –

November 8, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Affymax, Inc. (NASDAQ: AFFY) today reported financial results for the third quarter ended September 30, 2012. The net loss for the third quarter of 2012 was $24.6 million (or ($0.68) per share) compared to a...

November 8, 2012

SEATTLE--(BUSINESS WIRE)--Davis Wright Tremaine LLP today announced that its client, Richard J. Klein, former chief financial officer of the Seattle biopharmaceutical company Omeros Corporation, has received a $3.94 million payment to settle his...

November 8, 2012

WEST ORANGE, N.J.--(BUSINESS WIRE)--After four straight quarters of moderate growth in hiring demand, the ZRG Global Life Sciences Hiring index posted a 12.1% decrease, ending the quarter at 77.2%.

November 8, 2012

PHOENIX--(BUSINESS WIRE)--Greater Phoenix launches unique program after California passes $6 billion tax initiative

November 8, 2012

FRAMINGHAM, Mass.--(BUSINESS WIRE)--AB SCIEX, Phenomenex and Peak Scientific take mobile laboratory on European MASStastic Voyage Tour

November 8, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Inotek Pharmaceuticals Corp., a leader in the development of innovative drug candidates to address significant diseases of the eye, today announced that a multi-center, randomized, double-masked, placebo-...

November 8, 2012

DENVER--(BUSINESS WIRE)--April Giles, Executive Vice President of the Colorado BioScience Association (CBSA), has been named President & CEO following a national executive search.

November 8, 2012

SAN DIEGO--(BUSINESS WIRE)--New Studies Presented at the 2012 U.S. Psychiatric and Mental Health Congress Explore the Role of L-Methylfolate in Antidepressant Therapy

November 8, 2012

CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) (Alexion or the Company) today announced that the Company’s Board of Directors has authorized the repurchase of up to $400 million of Alexion common stock. Under the...

November 8, 2012

ANAHEIM, Calif.--(BUSINESS WIRE)--During the ACAAI annual meeting, Physicians are Reminded of the Need to Raise Awareness of the Burden of Allergies and Need For Appropriate Diagnosis and Treatment

November 8, 2012

TEMPE, Ariz.--(BUSINESS WIRE)--CRA Holdings, LLC announced today that it has acquired Radiant Research, Inc. CRA Holdings is the company that also owns Clinical Research Advantage (CRA), another major player in the SMO market.

November 8, 2012

RENO, Nev. & BONADUZ, Switzerland--(BUSINESS WIRE)--Hamilton Robotics in collaboration with GE Healthcare Life Sciences introduces the easyPunch STARlet™ workstation, the first fully automated system integrating sample card punching.

November 8, 2012

LEXINGTON, Mass. & SAN FRANCISCO--(BUSINESS WIRE)--Leading European Research Institutions Select RainDance’s ThunderStorm™ System for High-Throughput Targeted Sequencing

November 8, 2012

CHARLOTTE, N.C.--(BUSINESS WIRE)--Premier healthcare alliance experts to discuss reform, data integration and waste management in November

November 8, 2012

CONCORD, Calif.--(BUSINESS WIRE)--Dr. Laurence Corash, Cerus' chief medical officer, is scheduled to present at the Stephens Fall Investment Conference in New York at 1:00 PM ET on Wednesday, November 14, 2012.

November 8, 2012

AMSTERDAM--(BUSINESS WIRE)--AIMM Therapeutics, a next generation antibody company co-founded by Hergen Spits, PhD, today announced the appointment of Jan de Vries, PhD, as CEO and John Womelsdorf, PhD, as VP BD.

November 8, 2012

SAN DIEGO--(BUSINESS WIRE)--Critical Diagnostics, makers of the Presage® ST2 Assay, announced today that during a presentation at the American Heart Association Scientific Sessions in Los Angeles, the results of a study conducted through the Mayo...

November 8, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nimbus joins a select number of prestigious pharmaceutical and biotechnology companies that have entered into Privileged Partnership Agreements with Proteros.

November 8, 2012

HAYWARD, Calif.--(BUSINESS WIRE)--Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the Company will present at the Credit Suisse 2012 Healthcare Conference on Wednesday, November 14, at 1:00 p.m. Mountain Standard Time. The conference...

November 8, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Cutting Edge Information study finds that drug manufacturers initiate the majority of Phase IV clinical testing.

November 8, 2012

STOCKHOLM--(BUSINESS WIRE)--Tobii Technology’s partner i2Eye Diagnostics has developed a portable, patient-friendly solution — Saccadic Vector Optokinetic Perimetry (SVOP)— that assists clinicians in the diagnosis of ophthalmic and neurological...

November 8, 2012

SAN DIEGO--(BUSINESS WIRE)--SNMX 3Q12 Results: Market launch of a product containing S6821 Bitter Blocker initiated; regulatory approvals for Savory and Sweet Taste Programs. Call today 11am EST; audio at IR tab,...

November 8, 2012

LEIDEN, The Netherlands & SEATTLE--(BUSINESS WIRE)--ProFibrix Passes Halfway Mark of Patient Enrolment in Pivotal Phase III with Fibrocaps and Successfully Concludes Safety Review Assessment

November 8, 2012

LA JOLLA, Calif.--(BUSINESS WIRE)--Auspex Pharmaceuticals Closes $25 Million Series D Financing; Company Planning to Start Phase 3 Clinical Trial for Treatment of Movement Disorder (Chorea) Associated with Huntington’s Disease.

November 8, 2012

FORT COLLINS, Colo.--(BUSINESS WIRE)--Inviragen and the International Vaccine Institute (IVI) are conducting studies to determine the incidence, cost and epidemiology of dengue infection in Colombia and Thailand.

November 8, 2012

MORRISTOWN, N.J.--(BUSINESS WIRE)--Durata Therapeutics CEO Paul R. Edick will present an overview of the company at the Credit Suisse Healthcare Conference at The Arizona Biltmore in Phoenix, AZ on Nov. 15 at 3:00p.m. MST.

November 8, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will present at the Lazard Capital Markets 9th Annual Healthcare Conference being held in New York City. Harvey J. Berger, M.D., chairman and...

November 8, 2012

CINCINNATI--(BUSINESS WIRE)--Meridian Bioscience, Inc.: GENERAL HIGHLIGHTS Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today: reported record fourth quarter and full-year fiscal 2012 net sales of $43.7 million and $173.5 million,...

November 8, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Repligen Corporation (NASDAQ: RGEN) today reported financial results for its third quarter and year-to-date period ended September 30, 2012. The Company reported net income for the three-month period ended...

November 8, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zalicus reports financial results for the third quarter ended September 30, 2012.

November 8, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals to Present Corporate Update at Credit Suisse 2012 Healthcare Conference in Phoenix on November 15th

November 8, 2012

EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Paul K. Wotton, Ph.D., President and Chief Executive Officer, will present at the Jefferies 2012 Global Healthcare Conference on Thursday November 15, 2012 at...

November 8, 2012

HAYWARD, Calif.--(BUSINESS WIRE)--Aradigm Corporation today announced financial results for the third quarter and nine months ended September 30, 2012.